Evidence map›Paper›PMID 39702694›Full record

ArticleAnnals of nuclear medicine2025

Imaging of cardiac amyloidosis using dynamic

Chio Okuyama, Yasutaka Inuzuka, Yuzo Takeuchi, Kohsuke Asagoe, Shinya Kagawa, Miki Ito, Kuninori Kusano, Yoshiharu Fujita, Hiroyuki Watanabe, Masahiro Ono and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chio OkuyamaClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan. okuyama@res.med.shiga-pref.jp.ORCID http://orcid.org/0000-0002-9088-8917
Yasutaka InuzukaDepartment of Cardiology, Shiga General Hospital, Moriyama, Japan.
Yuzo TakeuchiDepartment of Cardiology, Shiga General Hospital, Moriyama, Japan.
Kohsuke AsagoeDepartment of Hematology, Shiga General Hospital, Moriyama, Japan.
Shinya KagawaClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.
Miki ItoClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.
Kuninori KusanoClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.
Yoshiharu FujitaClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.
Hiroyuki WatanabeGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Masahiro OnoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Tatsuya HigashiClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to evaluate the diagnostic ability of 5-(5-(2-(2-(2-

methodsThe subjects were patients diagnosed with proven amyloidosis (n = 16) including transthyretin cardiac amyloidosis (ATTR-CA) (n = 7) and light chain amyloidosis (AL amyloidosis) (n = 9), of which 4 and 5 with (AL-CA) and without (AL-nCA) cardiac involvement, and 4 control subjects suffering from some symptoms of cardiac failure without amyloidosis (CTL). Thirty minutes dynamic

resultsDiffuse

conclusions

Indexed as

AmyloidosisBenzofuransPositron-Emission TomographyPositron Emission Tomography Computed TomographyAgedAged, 80 and overFemaleHumansMaleMiddle AgedBenzofurans18F-FPYBF-2Amyloid PETCardiac amyloidosisDynamic PET

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.